Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Caprius(CAPR), Breast MRI(former ANMR/MAMO) -- Ignore unavailable to you. Want to Upgrade?

To: Kenneth Xavier who wrote (2490)	4/22/1998 1:35:00 PM
From: luis a. garcia	Read Replies (1) \| Respond to of 2615

Thanks Ken check this out... Arkansas is running dc Harms is got 30 day test period in force, don't know if it have a grand opening but it should. Got some fresh info from the company last night. Too late to read it all.. but I will. 50M shares??? not an issue at this time. There is cash for operations on hand and a line of credit with several banks... they don't wish to publicize because additional lenders may be contacted or something like that... That money is to go to partnerships which are revenue producing period. no dilution there. Other two sites Maggee and Englewood whatever are solid and as I reported much to do with construction of a shielded Rf room to house the Aurora system. Caprius has a ready made construction book with all necesary contracting and materials it runs 100k ... Red tape gets in the act and they come in late and at twice the cost... that is life in contemporary hospitals in America. each runs like a banana republic the more I hear about it the more I get sick... Radiologists love the systems otherwise. There are new systems about to hit and they can not be disclosed until they do. The video I got and the marketing materials look fresh, to go with the new Caprius, in the video dc Sawdoski said MRi is 95% effective at detecting malignancy... I think its 99% but I will watch it again to make sure. dc Harms papers suggest MRi is an emerging modality which with the right machine etc cost effective solution will be a super adjunct to mammography. Turns out the early detection capability the machine has over xrays is what will save the most lives. They also talked about a new kind of biopsy and you know they have applied for PMA for it at this time so in a year or so we may have the newest and the best biopsy tool in the market that works with MRi. There are a lot of grey areas that they touched on which i will analyze... such as the benefit of scanning a patient with cancer prior to surgery and after surgery to monitor reocurrences and to map out the breast conservation procedure. Medicine is increasingly performing breast conservation as oppossed to mastectomy. there will be 180,000 deaths this year due to breast cancer... same number for prostrate cancer... I wonder what temoxifin will do for that???? You are not installing a new machine in a hospital... you are reshaping the radiology floor and you are reshaping the radiology work flow in the institution and you are educating the radiology staff and the hospital administration.... its no small task. regards luis